The 12 closest competitors and alternatives to Idorsia Pharmaceuticals Ltd among pharmaceuticals, biotech companies — ranked by similarity to what Idorsia Pharmaceuticals Ltd actually does, not by market-cap band.
Subscribe to see Idorsia Pharmaceuticals Ltd’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Idorsia Pharmaceuticals Ltd is a biopharmaceutical company that conducts drug discovery, clinical development, and commercial operations to provide transformative treatments for patients. The company focuses on researching and developing therapeutic products and vaccines targeting conditions such as insomnia, hypertension, and Fabry disease.
Idorsia Pharmaceuticals Ltd is a pharmaceuticals, biotech company headquartered in Switzerland. Xcout tracks 11 named people at Idorsia Pharmaceuticals Ltd, including Jean-Paul Clozel (Chairman of the Board, interim CEO).
5 more named people on record for Idorsia Pharmaceuticals Ltd, with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to Idorsia Pharmaceuticals Ltd by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Pharmaceuticals
Ipsen is a global biopharmaceutical company that researches, develops, and commercializes innovative medicines. It primarily serves patients suffering from conditions in the fields of oncology, rare diseases, and neuroscience.
Pharmaceuticals
Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic solutions that address critical unmet medical needs. The company currently offers two approved treatments: HETLIOZ, prescribed for non-24-hour sleep-wake disorders, and Fanapt oral tablets, used in the management of schizophrenia. Vanda maintains an active and diverse development pipeline, exploring new applications for its existing therapies and advancing a range of novel compounds. This includes expanding HETLIOZ (tasimelteon) to potentially treat conditions such as jet lag disorder, Smith-Magenis Syndrome, pediatric Non-24, autism spectrum disorder, and delayed sleep phase disorder. Fanapt (iloperidone) is being investigated for bipolar disorder, alongside the creation of a long-acting injectable formulation for schizophrenia. Other promising candidates in development include: Tradipitant (VLY-686): A small molecule neurokinin-1 receptor (NK-1R) antagonist for atopic dermatitis, gastroparesis, and motion sickness. VTR-297: A small molecule histone deacetylase inhibitor, primarily for hematologic malignancies but with broader oncology potential. VQW-765: A small molecule nicotinic acetylcholine receptor partial agonist targeting psychiatric disorders. A portfolio of cystic fibrosis transmembrane conductance regulator (CFTR) activators and inhibitors aimed at dry eye and ocular inflammation. BPO-27: For secretory diarrhea disorders, including cholera. VHX-896: The active metabolite of iloperidone. Vanda Pharmaceuticals Inc. markets its products in the United States, Europe, and Israel. The company was established in 2002 and is headquartered in Washington, D.C.
Biotechnology, Pharmaceuticals
Novartis is a global healthcare company that researches, develops, and manufactures innovative medicines across therapeutic areas such as oncology, immunology, neuroscience, and cardiovascular diseases. The company serves patients, healthcare professionals, and healthcare systems worldwide by providing pharmaceutical treatments and managing clinical trials.
Pharmaceuticals
Chiesi Farmaceutici is a global biopharmaceutical group that researches, develops, and commercializes therapeutic solutions for patients. The company focuses primarily on respiratory health, rare diseases, and specialty care.
Pharmaceuticals, Biotechnology & Life Sciences
Island Pharmaceuticals Ltd is an Australian antiviral drug development company based in Melbourne, Australia, focused on addressing infectious diseases.
Pharmaceuticals
Indus Pharma is a pharmaceutical company headquartered in Pakistan that develops, manufactures, and markets branded generic healthcare products globally.
Pharmaceuticals
Grünenthal is a global pharmaceutical company that researches, develops, and commercializes innovative treatments and medicines with a primary focus on pain management and related diseases. Operating as a science-based business, the company serves patients worldwide by delivering therapies for conditions such as chronic pain, rare diseases, and neurobiological indications.
Pharmaceuticals
Sandoz Group AG is a Switzerland-based pharmaceutical company focused on generic and biosimilar medicines. It develops, manufactures, and supplies lower-cost medicines to healthcare providers, patients, and public health systems worldwide.
Pharmaceuticals
GSK is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients globally. Its research and development efforts focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
Pharmaceuticals
Basilea Pharmaceutica Ltd is a pharmaceutical company focused on developing and commercializing medicines, particularly anti-infective treatments such as antibiotics and antifungals. It serves healthcare providers and patients, primarily in markets where its products are approved and distributed.
Pharmaceuticals
CSL Vifor is part of the global biotechnology company CSL, focusing on the development and delivery of medical treatments for patients. Specifically, the company specializes in addressing therapeutic areas such as iron deficiency and nephrology.
Pharmaceuticals, Biotechnology & Life Sciences
IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms. The company furnishes comprehensive analytical support, including the establishment of testing methodologies, stability assessments utilizing specialized chambers, and quality control laboratory services for both chemical and microbiological applications. Furthermore, its service offerings span project management, chemical processing, advanced analytical chemistry, pharmacy support, clinical trial packaging, and regulatory compliance assistance, alongside pharmaceutical development expertise across diverse dosage forms. Notably, IDT Australia also provides medicinal cannabis products and a broad array of contract manufacturing solutions. Established in 1975, the firm is headquartered in Boronia, Australia.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Idorsia Pharmaceuticals Ltdand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →